tiprankstipranks
Trending News
More News >
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
Advertisement

Dyne Therapeutics (DYN) Stock Statistics & Valuation Metrics

Compare
348 Followers

Total Valuation

Dyne Therapeutics has a market cap or net worth of $1.31B. The enterprise value is $723.07M.
Market Cap$1.31B
Enterprise Value$723.07M

Share Statistics

Dyne Therapeutics has 141,545,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding141,545,360
Owned by Insiders11.38%
Owned by Institutions0.02%

Financial Efficiency

Dyne Therapeutics’s return on equity (ROE) is -0.50 and return on invested capital (ROIC) is -52.60%.
Return on Equity (ROE)-0.50
Return on Assets (ROA)-0.46
Return on Invested Capital (ROIC)-52.60%
Return on Capital Employed (ROCE)-0.53
Revenue Per Employee0.00
Profits Per Employee-1.65M
Employee Count192
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio1.36
Price to Fair Value3.52
Price to FCF-3.63
Price to Operating Cash Flow-2.84
PEG Ratio0.35

Income Statement

In the last 12 months, Dyne Therapeutics had revenue of 0.00 and earned -317.42M in profits. Earnings per share was -3.37.
Revenue0.00
Gross Profit0.00
Operating Income-343.89M
Pretax Income-317.42M
Net Income-317.42M
EBITDA-315.18M
Earnings Per Share (EPS)-3.37

Cash Flow

In the last 12 months, operating cash flow was -319.73M and capital expenditures -3.17M, giving a free cash flow of -322.89M billion.
Operating Cash Flow-319.73M
Free Cash Flow-322.89M
Free Cash Flow per Share-2.28

Dividends & Yields

Dyne Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.19
52-Week Price Change-79.25%
50-Day Moving Average11.01
200-Day Moving Average17.29
Relative Strength Index (RSI)52.18
Average Volume (3m)3.21M

Important Dates

Dyne Therapeutics upcoming earnings date is Jul 31, 2025, Before Open (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateJul 31, 2025
Ex-Dividend Date

Financial Position

Dyne Therapeutics as a current ratio of 15.60, with Debt / Equity ratio of 3.49%
Current Ratio15.60
Quick Ratio15.60
Debt to Market Cap<0.01
Net Debt to EBITDA1.31
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Dyne Therapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Dyne Therapeutics EV to EBITDA ratio is -5.73, with an EV/FCF ratio of -6.13.
EV to Sales0.00
EV to EBITDA-5.73
EV to Free Cash Flow-6.13
EV to Operating Cash Flow-6.18

Balance Sheet

Dyne Therapeutics has $677.49M in cash and marketable securities with $23.33M in debt, giving a net cash position of -$654.16M billion.
Cash & Marketable Securities$677.49M
Total Debt$23.33M
Net Cash-$654.16M
Net Cash Per Share-$4.62
Tangible Book Value Per Share$6.69

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Dyne Therapeutics is $37.54, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$37.54
Price Target Upside306.28% Upside
Analyst ConsensusStrong Buy
Analyst Count14
Revenue Growth Forecast
EPS Growth Forecast14.93%

Scores

Smart Score8
AI Score43
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis